Vincristine is the active ingredient in an antineoplastic drug known commercially as Oncovin, which is suitable for the treatment of various types of cancer, including leukemia, lung and breast cancer.
Its action is to interfere with the metabolism of amino acids and prevent cell division, which decreases the risk of cancer spreading throughout the body.
This medicine is available as an injection and should be administered by a healthcare professional.
Vincristine is a drug indicated for the treatment of the following types of cancer:
In addition, this remedy is also indicated for the treatment of fungal fungi and idiopathic thrombocytopenic purpura. Learn what it is and how to identify symptoms of idiopathic thrombocytopenic purpura.
This medicine should be administered intravenously by a health professional and the oncologist should determine the dose and duration of treatment.
In general, the dose is as follows
Adults
Children
The duration of treatment should be determined by the oncologist
This medicine is contraindicated in people with hypersensitivity to the components of the formula and in patients with the demyelinating form of Charcot-Marie-Tooth syndrome.
In addition, it should not be used by pregnant women and breastfeeding women should discontinue breastfeeding during vincristine treatment.
Some of the most common side effects that can occur during vincristine treatment are hair loss, constipation, body pain, decreased white blood cells, loss of sensation, difficulty walking and loss of reflexes.
The most serious side effects that can occur are neuromuscular disorders.